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proper maturation of synaptic circuits during development, and disruption of this process by 5-AzaC could
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pesticides, nicotine, etc.) can interfere with brain development during
critical periods and lead to a higher risk of developmental disabilities
in adulthood [2–7]. According to recent estimates from the Centers for
Disease Control and Prevention in the United States, approximately
15% (1 in 6) of children between the ages of 3 and 17 have one or
more developmental disabilities [8]. Adults with developmental disabil-
ities experience many health discrepancies, such as physical, mental,
and social problems, that hamper their quality of life.Many drugs [1], al-
cohol [9–11] and environmental chemical agents [4] are shown to be
teratogenic when administered during pregnancy, particularly during
the period of organogenesis, neuronal growth and sprouting and synap-
se formation [12,13]. Recent advancements in epigenetic research
suggest that changes in DNA methylation and post-translational modi-
fication of DNA-associated histone proteins play a highly significant
role in the teratogenic effects of many environmental agents [14–17],
including alcohol [18].
In our earlier study, we established that the transient treatment of
young mice with ethanol on postnatal day 7 (P7), which corresponds
to the third trimester of human pregnancy, caused significant neurode-
generation, caspase-3mediated degradation of DNAmethyltransferases
(DNMT1 and DNMT3A) and reduced DNA methylation [19]. At adult-
hood, the P7 alcohol-treated mice exhibited long-lasting synaptic and
behavioral abnormalities [20–25]. DNA methylation is maintained by
the combined function of DNMTs [26–30] and through the action of
ten-eleven translocation (TET) proteins [31]. Methylated DNA functions
during development to regulate gene expression [32]. Based on these
observations, the present study was undertaken to assess whether ad-
ministration of 5-azacytidine (5-AzaC), which is a DNMT inhibitor, to
P7 mice inhibit DNA methylation and causes caspase-3 activation (a
marker of neurodegeneration) in neonatal mice and behavioral abnor-
malities in adulthood.We administered 5-AzaC to P7mice and evaluat-
ed DNA methylation, caspase-3 activation and signaling events in
neonatal mice. To understand the mechanism of 5-AzaC, we also used
cannabinoid receptor type 1 (CB1R) knockouts, histonemethyltransfer-
ase (G9a) inhibitor or CB1R antagonist; all were shown to prevent cas-
pase-3 activation in alcohol-treated P7 mice [22,24]. At adulthood, we
investigated long-term potentiation (LTP) and object, spatial and social
memory behaviors. The findings suggest that 5-AzaC exposure in P7
mice induces DNA hypomethylation and neurodegeneration and im-
pairs ERK1/2 activation and Arc expression in neonatal mice and causes
long-lasting Arc deficits and behavioral abnormalities in adult mice. Our
studyprovides novel insights and suggests that DNAmethylation-medi-
ated mechanisms appear to be essential for the maturation of synaptic
events and that the disruption of this process, even transiently, delays
the acquisition of mature cognitive processes.
2. Materials and methods
2.1. Study animals
C57BL/6Jmicewere generated from a breeding colony at theNathan
Kline Institute (NKI). Cannabinoid receptor type 1 (CB1R) knockout
(KO) and wild-type (WT) male and female littermates were obtained
from a CB1R heterozygous [33] (C57BL/6J background) breeding colony
at the NKI. All mice were housed (21–24 °C with 40–60% humidity) in
groups of four, with water and food available ad libitum on a 12 h
light-dark cycle. The CB1R KO/WTmice were genotyped by polymerase
chain reaction (PCR) of genomic DNA obtained frommouse tails, as de-
scribed in our previous study [34]. The animal care and handling proce-
dures followed NKI Institutional Animal Care and Use Committee and
National Institutes of Health guidelines.
For each treatment group, four to seven pups from14different litters
were analyzed.2.2. Drug treatments
The mouse pups were culled to four or six pups per litter. For each
experimental group, six to ten pups from ten different litters were ana-
lyzed. On the day of treatment, half of the animals (male and female)
from each litter were subjected to a subcutaneous (s. c.) injection of sa-
line and the other half were injected with 5-AzaC at P7 (based on the
day of birth). 5-AzaC (Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA)was dissolved in sterile saline solution. A 5-AzaC (0–10mg/kg) so-
lution was administered by s. c. injection in a volume of 5 μl/g body
weight. Saline solution was injected as a control. To identify the events
involved in the neurodegenerative effects of 5-AzaC, we used Bix, SR
and CB1RKO mice in our study to rescue 5-AzaC-induced activation of
caspase-3 in P7 mice. In our earlier studies [22,24,35], we showed that
a 1mg/kg (Bix or SR) pretreatmentwasmore effective at preventing al-
cohol-induced caspase-3 activation in P7 mice. We evaluated whether
Bix or SR was effective in preventing 5-AzaC-induced caspase-3 activa-
tion in P7 mice. Bix-01294 (2-(Hexahydro-4-methyl-1H-1,4-diazepin-
1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-
quinazolinamine trihydrochloride) (histone methyltransferase or G9a/
G9a-like protein (GLP) inhibitor (Bix) Cayman, Michigan, USA) (n = 6
pups/group) and SR141716A [N-piperidino-5-(4-chlorophenyl)-1-
(2,4-dichlorophenyl)-4-methyl-3-pyrazole carboxamide] (CB1R antag-
onist, (SR)) (n = 6 pups/group) (gift from RBI, Natick, MA) were dis-
solved separately in alcohol (10 μl), followed by Tween 80 (10 μl), and
the volume was made up with sterile saline solution. Bix or SR was ad-
ministered (1mg/kg) by s. c. injection at a volume of 5 μl/g bodyweight
30 min before the 5-AzaC (5 mg/kg) treatment. The vehicle [alcohol
(10 μl) followed by Tween 80 (10 μl) and saline] was administered as
a control. Pups remained with the dams until they were sacrificed,
and their brains were removed 4–72 or 8 h after the 5-AzaC or Bix or
SR injections, respectively, and processed for the various analyses as de-
scribed below. After the P7 treatment with saline or 5-AzaC, three-
month-old mice derived from different litters were used for long-term
potentiation (LTP) and the learning andmemory behavioral tests, as de-
scribed below. Separate cohorts of mice were used for each behavioral
analysis.
2.3. DNA methylation assay
For the DNA methylation assay, the pups were sacrificed by decapi-
tation 8 h (the optimum time for maximum caspase-3 activation) after
5-AzaC injection (0–10 mg/kg; 6 pups from three different litters/
group), and the hippocampal and neocortical tissues were dissected,
flash frozen and stored at −80 °C. Genomic DNA was isolated from
the hippocampus and neocortex using a Qiagen DNA Extraction Kit
(Qiagen Sciences, Maryland, USA). The global DNA methylation levels
were evaluated using an Epigentek (Farmingdale, NY, USA)MethylFlash
DNA Methylation Quantification Kit (Colorimetric) according to the
manufacturer's instructions, as described previously [28]. The 5-
methylcytosine (5-mC) fraction of the DNA was determined using cap-
ture and detection antibodies, and then absorbance was measured at
450 nm. DNA oligomers containing synthetic unmethylated (50% of cy-
tosine) and methylated (50% of 5-mC) residues (Epigentek,
Farmingdale, NY, USA) were included as negative and positive controls,
respectively. The percentage of 5-mC was calculated using the formula
provided in the kit and was normalized to the percentage of the saline
(the graphs represent the DNAmethylation levelsmultiplied by an arbi-
trary factor to set the saline to 100).
2.4. DNA methylation dot blot
Genomic DNA was isolated from the P7 saline- and 5-AzaC-treated
mouse hippocampi, neocortices, and cerebella (n = 8 pups from 4 dif-
ferent litters/group) using a Qiagen DNA Extraction Kit (Qiagen Sci-
ences, Maryland, USA). 150 ng, 100 ng and 50 ng of DNA were dot-
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1 μl per sample. TheNCmembraneswere allowed to dry and then cross-
linked by exposing the membrane to UV for 15 s using a UV
Staratalinker 1800. The NC membrane was blocked with 2.5% non-fat
milk in Tris-buffered saline (1 h at room temperature). The NC mem-
brane was incubated with a primary rabbit-anti-5-methylcytosine anti-
body (1:500, # BY-MECY-0100, AnaSpec Inc., Fremont, CA) at room
temperature (3 h) or 4 °C (overnight). The NC membrane was washed,
incubated with a secondary antibody (1:1000 for 30 min at room tem-
perature), developed using ECL reagent, and processed as described by
our laboratory [36]. The dot blots were normalized to the percentage
of the saline.
2.5. Immunohistochemistry (IHC)
Eight hours (the optimum time for maximum caspase-3 activation)
after the 5-AzaC treatment (5 mg/kg; 5 pups from four different litters/
group), the pupswere anesthetizedwith isoflurane and perfusedwith a
cacodylate buffer (0.05 M) (pH 7.2) solution containing 4% paraformal-
dehyde and 4% sucrose. Serial brain sections (40 μm)were cut coronally
throughout each whole brain. The free-floating sections (−2 to
−2.6 mm from Bregma in the Paxinos atlas [37]) were chosen from
treated and control groups for immunohistochemistry. In dual labeling
studies, the free-floating brain sections obtained 8 h after saline or 5-
AzaC treatment were subjected to a dual immunofluorescence method
as described previously [24,35]. To labelmethylated cytosine in the neu-
rons, we used anti-mouse-5mC (1:1000; # Bi-MECY-0100, AnaSpec,
Inc., Fremont, CA) and anti-rabbit-NeuN (1:500; # 24307, Cell Signaling
Technology, Danvers, MA) in our experiments. The secondary antibod-
ies conjugated with Alexa Fluor 488 and 568 (Invitrogen, NY, USA)
were used in these studies. In anti-rabbit-5mC and anti-mouse-NeuN
staining, both of the primary antibodies were omitted from the
immunolabeling process to confer specificity of secondary antibodies.
The amount of colocalization of 5-mC with NeuN positive neurons
wasmeasured quantitatively byManders' correlation coefficients as de-
scribed previously [38] using LSM-880 with Airyscan and Zen Imaging
software. Colocalization was analyzed by selecting CA1, retrosplenial
cortex and cerebellum brain regions. For CC3 staining, free-floating cor-
onal brain sections were immunostained with an anti-rabbit cleaved
caspase-3 antibody (Asp175, CC3, polyclonal, #9961, 1:500, Cell Signal-
ing Technology, Danvers, MA, USA). Stainingwas detected with ABC re-
agents (Vectastain ABC Elite Kit, Vector Labs, Burlingame, CA, USA) and
a peroxidase substrate (DAB) Kit (Vector Labs) [24,35]. As a control for
secondary antibody specificity, the primary antibodies were omitted
from the reactions. Three coronal sections/mice/group were used for
counting. Countingwas performed using stereological dissector [39] es-
timating mean numerical densities of CC-3 positive cells. An unbiased
counting area (at least three non-adjacent fields in a section)
(0.05 × 0.05mm; dissector height, 0.07mm) and a high aperture objec-
tive was used for the sampling. Averages of 4 nonadjacent sections per
pup were used to determine the number of CC-3 positive cells within
the CA1 and RSC regions. A Nikon Eclipse TE2000 inverted microscope
(DXM1200F, Morrell Instrument Company, Melville, NY, USA) with
2.5× or 40× objectives was used to capture all photomicrographs.
2.6. Protein extraction, electrophoresis and immunoblotting
For theWestern blot analysis, the 10 pups/treatment group from five
different litters were sacrificed by decapitation 4–72 h after 5-AzaC in-
jection (0–10 mg/kg, n = 10 pups from five different litters/group or
5mg/kg for 8 h, n=10pups from5different litters/group), and the hip-
pocampal and neocortical tissues were dissected, flash frozen and
stored at −80 °C. The hippocampal and neocortical homogenates
were processed and subjected to immunoblotting [40,41]. Ponceau S
staining was used to verify equal protein loading in each blot. The
blots were incubated with a primary antibody, including anti-rabbitcleaved caspase-3 (CC3, amarker for an apoptotic cell death or neurode-
generation) (Asp175, polyclonal, #9661, 1:1000), anti-rabbit p44/42
MAPK (ERK1/2) (1:1000, #9102), anti-rabbit phospho-p44/42 MAPK
(1:1000, #9101; Cell Signaling Technology, Danvers, MA, USA), anti-
mouse activity regulated cytoskeleton-associated protein (Arc; #sc
17839, 1:1000; Santa Cruz Biotechnology) and anti-mouse-β-actin
(monoclonal, #3700, 1:1000, Cell Signaling Technology, Danvers, MA,
USA) at room temperature (3 h) or 4 °C (overnight) and processed as
described by our laboratory [36]. The blots that were incubated with a
secondary antibody (peroxidase-conjugated goat anti-mouse, #AP
124P, 1:5000, Millipore; or goat anti-rabbit, #AP132P, 1:5000,
Millipore) alone produced no bands.
2.7. Spatial recognition memory (SRM) using the Y-maze
SRM is based on the natural tendency of rodents to explore novel
areas [42] and was performed [43] using the symmetrical Y-maze
(Stoelting, Wood Dale, IL) exactly as we previously described [40,41].
Briefly, the experiment included 3-month-old male and female mice
that had been treated with saline or 5-AzaC (n = 8 mice from four dif-
ferent litters/group) at P7. During the training trials (10 min, training
trial) the entry to one arm (the novel arm) was blocked using a sheet
of opaque Perspex. After a 24h intertrial interval, themicewere allowed
to explore all three arms (3 min, preference trial). The number of en-
tries, the time spent in each arm and the first choice of entry were
noted manually and from video recordings by an observer who was
blinded to the treatment groups. Preference for the novel armwasmea-
sured using the following formula [Preference for the novel arm over
the familiar Other arm (Novel/Novel + Other)] as a ratio for discrimi-
nating both the time spent in the arms and number of arm entries
[41]. A discrimination ratio of N0.5 indicates a preference for the novel
arms.
2.8. Social recognition memory
The social recognition memory procedure [44,45] allows direct ac-
cess between the experimental and the stimulus mice and is widely
used to assess long-term memory in rodents [22,23,44,46,47]. Briefly,
three-month-old male mice that had been treated with saline or 5-
AzaC at P7 (n=8mice from four different litters/group)were subjected
to a social recognition memory test that was performed as described
previously [22]. An individualmalemousewas placed in a cage in anob-
servation room (dim light) andwas allowed to habituate to the new en-
vironment for 15 min. The experimental cages were the same as those
in which the animals were housed (plastic, 27 cm long × 16 cm
wide × 12 cm high). After 15 min, a male juvenile mouse (3–4 weeks
old) was immediately introduced into the cage with an adult for an ini-
tial contact trial of 2 min. After 24 h (intertrial delay), the same juvenile
mouse was placed back in the adult's cage for a 2-min test trial. The an-
imals were returned to their home cages during the 24 h period be-
tween the initial and the test trials. A trained observer continuously
timed the duration of the social investigation (with a hand-held stop-
watch). The scored social investigative behaviors include direct contact
with the juvenile while inspecting any part of the body (including
grooming, licking, and pawing); sniffing of the mouth, ears, tail, or
anogenital region; and close following (within 1 cm) of the juvenile
[44,45]. If the adult mouse did not investigate the young mouse for a
minimum of 24 s during the initial trial (i.e., 20% of the test time),
they were retested once with another juvenile. The trials with initial in-
vestigation times of b24 s were excluded from the analysis. Any aggres-
sive encounter between the animals was an immediate call for the
termination of the experiment, and these data were excluded from
the statistical analysis. The percentage of time spent in social investiga-
tionwas evaluated by dividing the investigation time during the second
exposure by the initial investigation time × 100.
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ORM is based on the natural tendency of rodents to explore novel
objects [48] and is widely used as a measure of memory in rodents
[40,41,49–51]. ORM was evaluated in a 40 × 40 cm open field
surrounded by 35-cm-high walls made of Plexiglas (Stoelting, Wood
Dale, IL) [24]. Twenty-four hours after habituation, three-month-old
male mice that had been treated with saline or 5-AzaC at P7 (n = 8
mice from four different litters/group) were subjected to the ORM
task [24,41,48]. Briefly, each mouse was subjected to a habituation ses-
sion (allowed to freely explore the open field for 5 min twice a day for
two days without any objects in the box). Twenty-four hours after ha-
bituation, the training (T1) sessionwas performed by placing individual
mice in the open field for 5 min with two identical objects (objects a1
and a2) placed in two adjacent corners at a 10 cm distance from the
walls. Twenty-four hours (retention) after training (T2), the mice
were allowed to explore the open field with one familiar (a1) and one
novel object (b1) for 5 min. Although all objects had similar textures
and sizes, they had distinct shapes and colors. Between trials, the objects
were rinsed with a 10% alcohol solution. Typical exploration was de-
fined as directing the nose toward the object at a distance of no N2 cm
and touching the object with the nose. Sitting on the object was not
treated as exploratory behavior. The total exploration time for bothFig. 1.5-AzaC treatment of P7mice inhibits DNAmethylation in themouse brain. (A) The global
(NC) and cerebellum (CB) tissues. HP, NC and CB of P7 mice after treatment with saline or var
group). (B) Global 5-mC-specific dot-blot intensities of genomic DNA prepared from theHP, NC
5-AzaC (5mg/kg bodyweight, s. c. 8 h). *p b 0.01 vs. saline. The amounts of 5-mC are shownas a
pups/group). *p b 0.01 vs. Saline. (C) Free-floating coronal brain sections (hippocampus, retrosp
immunohistochemistry with anti-mouse-5mC and anti-rabbit-NeuN to label methylated cyto
neurons in the hippocampus (CA1 region), retrosplenial cortex (RSC) and cerebellum (CB) (
bars = 10 μm.objects at T1 and T2 (24 h retention) was represented as e1 and e2, re-
spectively. The discrimination index (d2) was considered a means of
discriminating between familiar and novel objects and seems to be in-
dependent of the total exploration time [52]. The time spent exploring
each object during T1 and T2 was recorded by an observer who was
blinded to the treatment.
3. Long-term potentiation (LTP)
LTP is a lasting increase in synaptic strength, and it establishes the
crucial cellular mechanism of learning and memory [53]. Three-
month-old male mice (n = 5 mice from four different litters/group)
that had been treated with saline and 5-AzaC at P7 were sacrificed by
cervical dislocation, followed by decapitation. Hippocampal slices
(400 μm) were prepared [24] and recorded using standard procedures,
as previously described [22,24,40,41]. After sectioning, the slices were
placed in a recording chamber (29 °C) and continuously perfused with
artificial cerebrospinal fluid (ACSF in mM: 4.4 KCl, 124.0 NaCl, 25.0
NaHCO3, 1.0 Na2HPO4, 2.0 CaCl2, 2.0 MgSO4, and 10.0 glucose, osmo-
larity 290–300) bubbled with 95% O2 and 5% CO2. CA1 field excitatory
post-synaptic potentials (fEPSPs) were recorded by placing both the
stimulating and the recording electrodes in the CA1 stratum radiatum.
Basal synaptic transmission (BST) was measured by plotting the fiberDNAmethylation levelswere quantifiedusingDNA from thehippocampus (HP), neocortex
ious doses of 5-AzaC (0–10 mg/kg body weight, s. c. 8 h). *p b 0.01 vs. 0 mg (n = 6 pups/
and CB (150 ng, 100 ng and 5 ng of genomic DNA) of P7mice after treatmentwith saline or
percentage of the 5-mC-specific dot-blot intensities compared to the saline controls (n=8
lenial cortex and cerebellum) from both the groups (saline and 5-AzaC)were subjected to
sine in neurons. Manders coefficient analysis was used to evaluate 5-mC positive NeuN
cerebellar folia region). Error bars, SEM (n = 6 pups/group). *p b 0.01 vs. Saline. Scale
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scribed in detail [24]. Before theta-burst stimulation (TBS) (4 pulses at
100 Hz, with the bursts repeated at 5 Hz and each tetanus including
3 × 10-burst trains separated by 15 s), a baseline was recorded for
10 min at an intensity that evokes a response that is approximately
35% of the maximum evoked response. LTP was induced by TBS of the
Schaeffer collateral pathway. The responses were recorded for 2 h
after TBS andmeasured as fEPSP slopes, whichwere expressed as a per-
centage of the baseline.3.1. Statistical analysis
The experiments were evaluated with an equal number of mice/
treatment. All of the data are presented as the mean ± SEM. The data
were statistically analyzed by one- or two-way analysis of variance
(ANOVA) with Bonferroni's post hoc test. Statistical significance was
set at P b 0.05. The statistical analyses were performed using Prism soft-
ware (GraphPad, San Diego, CA).Fig. 2. The 5-AzaC treatment of P7mice induces neurodegeneration. (A)Western blot analysis o
s. c. 8 h) groups. (B) Western blot analysis of CC3 using cytosolic extracts of the HP and NC fro
staining confirmedequal loading of theprotein, andβ-actinwasused as a loading controls Error
retrosplenial cortex) from the saline- and 5-AzaC-treated (5 mg/kg, s. c. 8 h) animals were imm
neurons in the hippocampus and retrosplenial cortex. Scale bars= 200 μm. The hippocampal r
CC3-positive cells in the hippocampus and retrosplenial cortex were counted. Error bars, SEM4. Results
4.1. 5-AzaC treatment of P7 mice inhibits DNA methylation and activates
caspase-3
Previous studies report that the administration of the DNA meth-
ylation inhibitor 5-AzaC to pregnant animals causes apoptotic cell
death in the embryonic brain [54]. However, it is not knownwhether
the inhibition of DNA methylation by 5-AzaC for a short period dur-
ing synaptogenesis (a very sensitive stage for apoptotic cell death
[55–58]) causes caspase-3 activation. The results showed that 5-
AzaC inhibits DNA methylation in a dose-dependent manner (Fig.
1A; hippocampus, F4, 35 = 112, p b 0.01; neocortex, F4, 35 = 30,
p b 0.01; cerebellum, F4, 35 = 28, p b 0.01) (two-way ANOVA). We
also observed a significant reduction in the amount of 5-mC in the
genomic DNA from the 5-AzaC-treated P7 mice HP (F1, 46 = 25,
p b 0.01), NC (F1, 46 = 20, p b 0.01) and CB (F1, 46 = 15, p b 0.01)
(one-way ANOVA with Bonferroni's post hoc tests) compared to
the saline groups (1B). The dot blots were normalized to thef CC3HP, NC and CB in cytosolic extracts from the saline- and 5-AzaC-treated (0–10mg/kg,
m the saline- and 5-AzaC-treated (5 mg/kg, s. c.) groups at various time points. Ponceau S
bars, SEM (n=10 pups/group). (C) Free-floating coronal brain sections (hippocampus and
unostained with an anti-rabbit CC3 antibody. The white arrows indicate the CC3-positive
egion was enlarged to show the CC3-positive cells (*). The scale bars represent 50 μm. The
(n = 5 pups/group). *p b 0.01 vs. 0 h (saline).
Fig. 4.Pharmacological inhibition ofG9a/CB1Ror genetic ablation of CB1R fails to rescue 5-
AzaC-induced caspase-3 activation in P7 mice. (A) The mice were pre-treated with Bix
(1 mg/kg) or vehicle for 30 min and then exposed to 5-AzaC (5 mg/kg). The CC3 levels
in cytosolic extracts of the hippocampus (HP) and neocortex (NC) were determined by
Western blot analysis. (B) P7 CB1RWT mice were pre-treated with SR (1 mg/kg) or
vehicle for 30 min, and P7 CB1RKO mice were exposed to 5-AzaC (5 mg/kg). The CC3
levels in cytosolic extracts of the hippocampus (HP) were determined by Western blot
analysis. β-actin was used as a loading control. Error bars, SEM (n = 10 pups/group)
(*p b 0.01 vs. vehicle).
Fig. 3. 5-AzaC inhibits ERK1/2 phosphorylation and Arc protein expression in the neonatal
brain. Western blot analysis of pERK1/2, ERK1/2 and Arc in cytosolic extracts from the
hippocampus (HP) and neocortex (NC) of the saline- or 5-AzaC-treated groups; β-actin
was used as a loading control. Error bars, SEM (n = 10 pups/group) (*p b 0.01 vs. 0 h
(saline)).
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tiplied by an arbitrary factor to set the saline to 100). Manders coef-
ficient analysis suggests that 5-AzaC-treatment significantly
(p b 0.01) reduced the 5-mC positive NeuN neurons in hippocampus
(CA1 region), retrosplenial cortex (RSC) and cerebellum (CB) brain
regions (Fig. 1C) when compared to saline treatment groups.
5-AzaC also induces the formation of CC3 in the hippocampus (F4,
37= 55, p b 0.01) and neocortex (F4, 37= 58, p b 0.01) (Fig. 2A) (two-
way ANOVA) in a dose-dependent manner but did not induce the
formation of CC3 in the cerebellum (p N 0.05) at any of the doses ex-
amined. 5-AzaC also induces the formation of CC3 in the hippocam-
pus, (F1, 46 = 45, p b 0.01) and neocortex, (F1, 46 = 38, p b 0.01)
(one-way ANOVA with Bonferroni's post hoc tests) of neonatal
mice at 8 and 24 h. The CC3 levels returned to normal levels by
48 h after the 5-AzaC treatment (Fig. 2B). We then examined CC3
IHC after 8 h of 5-AzaC exposure. We counted the CC3-positive
cells (4 sections/brain) in the hippocampus and cortex [hippocam-
pus (F1, 11 = 54, p b 0.01) and cortex (F1, 11 = 80, p b 0.01) regions]
(one-way ANOVA). The results suggest that the 5-AzaC treatment
enhanced caspase-3 activation, as indicated by the increased number
of CC3-positive cells in the 5-AzaC-exposed brain sections (5 mg/kg,
s. c. at 8 h) (Fig. 2C).4.2. 5-AzaC treatment of P7 mice inhibits ERK1/2 phosphorylation and Arc
protein expression
To further evaluate the participation of intracellular signaling events
in the effects of 5-AzaC on the developing brain, we determined the
levels of both pERK1/2 (activated), ERK1/2 (total) and Arc proteins.
22 S. Subbanna et al. / Physiology & Behavior 167 (2016) 16–27The 5-AzaC treatment significantly reduced the pERK1/2 and Arc pro-
tein levels in the hippocampus (pERK1/2, F1, 37 = 34, p b 0.01; Arc, F1,
37 = 54, p b 0.01) and neocortex (pERK1/2, F1, 37 = 44, p b 0.01; Arc,
F1, 37= 59, p b 0.01) (one-way ANOVA) at 8 and 24 h. 5-AzaC treatment
failed to alter the total ERK1/2 protein levels at any time point (Fig. 3).
4.3. Bix or SR pre-administration or CB1RKO does not provide protection
against 5-AzaC-induced caspase-3 activation
The administration of the maximum dose of Bix (1 mg/kg) 30 min
before the 5-AzaC treatment failed to prevent caspase-3 activation
(Fig. 4A) in P7 mice (p N 0.05). Furthermore, in our previous studies,
both a CB1R antagonist (SR) and the CB1RKO mice prevented alcohol-
induced caspase-3 activation in P7 mice [24]. Pre-administration of SR
30 min before the 5-AzaC treatment in P7 mice failed to prevent cas-
pase-3 activation. Similarly, 5-AzaC-induced caspase-3 activation was
not prevented in the P7 CB1RKO mice compared to the WT littermates
(p N 0.05) (Fig. 4B). Consistent with our previous observations, Bix or
SR alone failed to activate caspase-3 in P7mice. These observations sug-
gest that alcohol-induced inhibition of DNAmethylation is possibly ini-
tiated upstream of DNMTs, and therefore the neurodegeneration
induced by the direct inhibition of DNMTs by 5-AzaC cannot be rescued
byBix or SR treatment or as a consequence of genetic ablation of CB1R in
mice.
4.4. 5-AzaC-exposed P7 mice exhibit normal ERK activation but impaired
Arc expression in adulthood
To further examine whether impaired ERK activation and Arc ex-
pression persist in adulthood, we determined the levels of pERK1/2 (ac-
tivated), ERK1/2 (total) and Arc proteins byWestern blot analysis using
specific protein antibodies. The 5-AzaC treatment significantly reduced
the Arc protein levels but not the pERK1/2 levels in the hippocampus
(Arc, F1, 37 = 34, p b 0.01; pERK1/2, F1, 37 = 2, p N 0.05) (One-way
ANOVA) and NC (data not shown) of adult mice. The 5-AzaC treatment
failed to alter the total ERK1/2 protein levels at any time points (Fig. 5).
4.5. Exposure of P7 mice to 5-AzaC induces learning and memory deficits in
adult mice
In the spatial recognition memory test, the P7 saline-treated adult
male and female mice more frequently entered the novel, previously
unvisited arm of the Y-maze (Arm Entry: [F1,20 = 36, p b 0.01]) and
spent more time within the novel arm (Time in arm: [F1,20 = 32,Fig. 5. 5-AzaC-induced deficits in ERK1/2 phosphorylation and Arc protein expression are long
cytosolic extracts of the hippocampus (HP) from the P7 saline- or 5-AzaC-treated adult mice;
0 h (saline)).p b 0.01]). In contrast, the P7 5-AzaC-treated adult male and female
mice showed a reduced preference for the novel arm (p b 0.01) and
spent less time (p b 0.01) in the novel arm compared to the P7 saline-
treated adult mice (Fig. 6A and B). We did not observe a significant dif-
ference (F1, 20 = 1.6, p N 0.05, one-way ANOVA) in the spatial recogni-
tion memory performance of the adult male and female mice that had
been treated with or without 5-AzaC at P7. Although the saline-treated
mice (male and female) selected the novel armas thefirst choice, the P7
5-AzaC-treated adult mice (male and female) showed a reduced prefer-
ence for the novel arm (Fig. 6C) (F1, 20= 40, p b 0.01, one-way ANOVA).
The other behavioral experimentswere carried out withmalemice only
due to the lack of a significant influence of gender in the Y-maze behav-
ioral studies.
In the social recognition memory performance task, the P7 5-AzaC-
treated adultmalemice exhibited a significant reduction in social recog-
nition memory performance compared to the saline-treated mice
(F1,20 = 48, p b 0.01, one-way ANOVA; Fig. 6D). The 5-AzaC treatment
of P7 mice for a short period impaired social recognition memory in
adult mice.
In the object recognition test, the 5-AzaC treatment at P7 had no sig-
nificant effect on the total exploration times [e1; F1, 20 = 2.0, p N 0.05;
e2; F1, 20 = 1.7, p N 0.05] (Fig. 7A) (one-way ANOVA) but impaired
ORT performance (F1, 20 = 49, p b 0.01, one-way ANOVA; Fig. 7B) in
adult male mice. Together, these behavioral tests suggest that the expo-
sure of P7 mice to 5-AzaC during an active synaptogenesis period dra-
matically impaired learning and memory behavior in adulthood that
are dependent on the limbic system without affecting the overall mice
movement that is mediated by the cerebellum.
4.6. The pharmacological inhibition of DNA methylation by 5-AzaC in P7
mice induces LTP deficits in adult mice
To understand whether the treatment of P7 mice with 5-AzaC for a
short period produces long-lasting LTP deficits, we performed in vitro
recordings in the Schaffer collateral pathway of hippocampal slices
(Fig. 8A) prepared from adult male mice (P90) that had been treated
with saline or 5-AzaC at P7. Increasing the stimulus intensity evoked ro-
bust I/O responses of the fEPSPs in both groups. The fEPSP I/O curvewas
not affected by 5-AzaC treatment (p N 0.05; Fig. 8B). The baseline fEPSP
was recorded at 60-s intervals for 10 min with stimulation at an inten-
sity equivalent to ~35% of the maximum evoked response. The TBS elic-
ited a typical fEPSP LTP [40,41] (Fig. 8C) in slices from adult mice that
had been treated with saline or 5-AzaC at P7. These responses were sta-
ble over 120 min. However, TBS evoked a significantly reduced fEPSP-lasting and persist into adulthood. Western blot analysis of pERK1/2, ERK1/2 and Arc in
β-actin was used as a loading control. Error bars, SEM (n = 10 pups/group) (*p b 0.01 vs.
23S. Subbanna et al. / Physiology & Behavior 167 (2016) 16–27slope in the slices (n= 10 slices/5mice/group) prepared from the P7 5-
AzaC-treated adult animals compared with slices from the saline-treat-
ed adult animals (F1, 20=33, p b 0.01, one-wayANOVA) (Fig. 8D). These
findings suggest that the treatment of P7 mice with 5-AzaC for a short
period during active synaptogenesis dramatically impairs LTP in adult
mice.
5. Discussion
In this study, we demonstrate for the first time that 5-AzaC-treat-
ment for a short period duringpostnatal brain development (active syn-
aptogenesis period, equivalent to the third trimester in humans)
induces DNA hypomethylation and neurodegeneration in P7 mice and
long-lasting synaptic plasticity and learning and memory deficits in
adulthood. Although we found a similar reduction of DNA methylation
in all the brain regions measured, the cerebellum is less susceptible to
5-AzaC-induced neurodegeneration at P7 than the neocortex and hip-
pocampus. This is possibly because the cerebellum is more sensitive toFig. 6. 5-AzaC treatment of P7 mice induces long-lasting impairments in spatial memory and so
the Y-maze. (A) Discrimination index [preference for the novel arm over the familiar other ar
treated male and female mice at 24 h after the first encounter with the partially opened maze
AzaC-treated animals (male and female combined) that selected the novel arm as the first cho
5-AzaC at P7 induces a loss of social recognition memory in adult male mice. The percent of t
mouse is shown for the saline- and 5-AzaC-treated mice. Error bars, SEM (n = 8 mice/group).external agents, including ethanol, at P4 but not at P7 in the neonatal
period [59–61]. Our findings suggest that the mechanism by which 5-
AzaC induces caspase-3 activation differs significantly from that of alco-
hol-induced caspase-3 activation in P7 mice [9]. This is partly because
pre-administration of a G9a/GLP inhibitor (Bix) [22,35] or CB1R antago-
nist (SR) [19,23,24], which are known to prevent alcohol-induced cas-
pase-3 activation, failed to rescue 5-AzaC-induced caspase-3 activation
in neonatal mice. Furthermore, the CB1RKO, which provides protection
against alcohol-induced caspase-3 activation [19,23,24], also failed to
rescue 5-AzaC-induced caspase-3 activation in neonatal mice. Although
future studies are required to identify the DNA hypomethylation-in-
duced regulation of apoptosis-related genes in P7 mice, it should be
noted that the DNA methylation inhibitor activity of 5-AzaC involves
its incorporation into cellular DNA/RNA, with subsequent sequestration
of DNA methyltransferases (DNMTs) through the formation of a cova-
lent bond between C6 of 5-AzaC and the cysteine thiolate of DNMTs
[62]. Both DNMT1 and DNMT3A are highly expressed during early
brain development compared to adulthood [28] and are involved incial recognition memory in adulthood. Spatial memory performance was measured using
m (Novel/Novel + Other)] for arm entries and (B) dwell time of the saline- and 5-AzaC-
. The dashed line denotes chance performance (0.5). (C) The percentage of saline- and 5-
ice 24 h after the first encounter with the partially open maze is shown. (D) Exposure to
ime spent in social investigation at 24 h after the first encounter with the same juvenile
*p b 0.01 vs. saline.
Fig. 7. Treatment of P7 mice with 5-AzaC causes objects recognition memory deficits in
adulthood. (A) The level of exploration was measured at el and e2 (24 h), namely the
time the saline- and 5-AzaC-treated male mice spent exploring the two objects in T1
and T2 (24 h). (B) Discrimination indices (d2) obtained from the saline- and 5-AzaC-
treated mice after 24 h retention intervals. e1 and e2 are measures of the total time
spent exploring both objects during T1 and T2, respectively. d2 is an index measuring
discrimination between the new and the familiar objects. Error bars, SEM (n = 8 mice/
group). *p b 0.01 vs. saline.
24 S. Subbanna et al. / Physiology & Behavior 167 (2016) 16–27the regulation of DNA methylation in both embryonic and adult brain
neurons [63–65]. Moreover, extensive apoptosis was observed in the
brains of DNMT1 knockout (KO) embryos just after gastrulation [66].
Furthermore, inhibition of DNMT1 activities, either via genetic ablation
or pharmacological treatment, protects injured neurons, suggesting that
a balanced level of DNA methylation is essential for neuronal survival
[67]. Conditional DNMT3A KO mice (lacking DNMT3A throughout the
entire brain) are normal at birth but die in young adulthood [63].
DNMT3A was shown to contribute to the survival of motor neurons
and the maintenance of the neuromuscular endplate structure [63]. In-
terestingly, the conditional deletion of both DNMT1 and DNMT3A in
postnatal post-mitotic neurons (P14) at the endof synaptogenesis failed
to induce neuronal loss but caused synaptic defects in adulthood [68].
Together, these findings suggest that DNA methylation levels during
embryonic and synaptogenesis are important for neuronal survival
and the proper maturation of neuronal circuits.
The DNA methylation pattern observed in adult cells is established
during gametogenesis and early embryonic development through a se-
quential process of demethylation and de novo methylation [69]. Al-
though our study demonstrates that 5-AzaC inhibits DNA methylation,
our study does not exclude other possible effects of 5-AzaC, such as in-
corporation into RNA and the inhibition of DNA, RNA, and protein syn-
thesis, and these events can also affect chromatin organization and
gene expression. Together, these studies suggest that the hypomethyla-
tion induced by short-term 5-AzaC treatment during periods of active
synaptogenesis (P7) may lead to increased genomic instability and, in
turn, neurodegeneration. Hence, DNA methylation is crucial for the
function of postnatal neurons in the brain. These observations are con-
sistent with previous studies demonstrating that 5-AzaC-induced
changes in DNA methylation could alter chromosomal architecture,
leading to chromosome instability [70] and changes in gene expression
[71–74].
The present caspase-3 activation results are consistentwith previous
studies in which 5-AzaCwas administered to pregnant animals as a sin-
gle dose at the 11th [75] or 13th day [76] of gestation (equivalent to the
first and second trimesters in humans, respectively), and this treatment
evoked significant apoptosis in the brain of fetuses 12–24 h after treat-
ment. Together, these findings suggest that exposure to 5-AzaC during
the first, second or third trimester of pregnancy is deleterious to the de-
veloping fetus. Our results are also consistent with several in vitro stud-
ies showing that 5-AzaC treatment caused apoptotic cell death not only
in cancerous cells [77–79] but also in many normal cells [75,76,80–82].
The present study is the first to demonstrate that postnatal adminis-
tration of 5-AzaC down-regulates ERK1/2 phosphorylation and Arc ex-
pression in both theneocortex and thehippocampus. Activated ERK1/2
signaling is critical inmediating the response to neurotrophic stimuli,
suchasnervegrowthfactorandbrain-derivedneurotrophicfactor,tosup-
port neuronal survival; the disruption of activated ERK1/2 signalinghas
been associated with neurodegeneration, synaptic deficits [20,24,83]
and abnormal brain development, leading to cognitivedysfunction [84].
The roles of Arc proteins in the mature neural network [85–88] have
been thoroughly studied, but their roles during development are less
clear.Moreover, both ERK1/2 activation andArc expression are induced
byneural activity or are increasedbyexperimental stimuli (glutamateor
electricalstimulation)orbynaturalstimulationthroughbehaviorallearn-
ingor experiencingnovel conditions [89–91].
Previous studies have identified the roles of DNA methylation and
demethylation in neural plasticity (LTP) and memory formation within
the adult hippocampus [68,92–95].We have used threememory behav-
iors that are dependent on the integrity of the hippocampus-entorhinal
cortex [48,96] (limbic system) [97,98] (spatial memory) as well as the
olfactory system [99] (social behavior). In humans, recognition memo-
ry, a subtype of declarative memory, is crucial for recalling various
events, objects and people [100] and can be tested in animals through
memory for an object (what), its spatial location (where) and the tem-
poral element (when) of an event [49,101–104]. Our findings suggestthat transient inhibition of DNAmethylation by 5-AzaC for a short peri-
od at P7 also produced long-lasting deficits in object, spatial and social
recognition memory and LTP abnormalities in adulthood. LTP has been
implicated in the activity-dependent refinement of neural circuits dur-
ing development and the formation of dendritic spines [105]. Therefore,
suppression of both ERK1/2 phosphorylation and Arc expression may
disrupt critical events, such as synaptic plasticity, during postnatal de-
velopment, leading to impairments in object, spatial and social recogni-
tion memory in P7 5-AzaC-treated adult mice. Furthermore, in our
previous studies, alcohol exposure at P7 resulted in DNA hypomethyla-
tion in neonatal mice [19] and also caused long-lasting abnormalities
object, spatial and social recognition memory and synaptic plasticity
in adult mice [22–24]. In addition, adult neurogenesis generates various
functional neural cell types from multipotent neural stem cells (NSCs)
in the particular zones of the mammalian brain throughout the life
time of an organism and may correlate with complex neuronal activi-
ties, such as learning and memory [106–108]. The observed deficits in
learning andmemory behaviorsmight also arise from the lack of protec-
tion of the newly generated functional neuronal cells from NSCs or im-
pairments in the neurogenesis process in adult mice treated with 5-
AzaC at P7 and should be investigated in future studies.
Conditional deletion of DNMT1 in mouse brain precursor cells in
vivo leads to global DNA hypomethylation and postnatal death of neu-
rons in several brain regions [109]. Targeted deletion of DNMT1 in the
dorsal forebrain causes the severe and progressive degeneration of cor-
tical and hippocampal neurons due to hypomethylation-induced neuro-
degeneration, both pre- and postnatally [110]. In addition, deletion of
DNMT1 leads to long-lasting deregulation of neuronal gene expression
and deficits in LTP, learning, and memory in adult mice [110,111]. In
micewith a brain-specific deletion of DNMT3A, global DNAmethylation
is not altered, but these mice exhibit abnormal motor neurons, neuro-
muscular junctions and premature death [63]. Although individual con-
ditional genetic ablation of DNMT1 or DNMT3A after P14 failed to alter
adult LTP, learning, ormemory, the double KO (deletion of both DNMT1
and DNMT3A) induced significant impairments in synaptic plasticity,
learning and memory in adult mice [68].
Although most developmental studies are limited to the genetic de-
letion of one or more DNA methylating enzymes (DNMTs), many adult
studies determine the function of DNA methylation in learning and
memory using 5-AzaC. For example, an infusion of 5-AzaC directly
Fig. 8. Exposure of P7mice to 5-AzaC induces LTP deficits in adultmice. (A) A schematic drawing showing the positions of the stimulating and recording electrodes in the CA1 region of the
hippocampus. (B) A summary graph showing the field input/output relationships for the P7 saline- and 5-AzaC-treated adult mice. Insert: An example of traces taken from representative
experiments showing the input/output relationships for the saline group. Although it is not shown, the other groups also exhibited comparable patterns. (C) The time course of the average
fEPSP slope obtained from theP7 saline- and 5-AzaC-treated adultmice. The fEPSP slopes fromeach LTP recordingwerenormalized to themean value of 10min recordings obtained before
stimulation. The arrows indicate the time of TBS (4 pulses at 100Hz, with bursts repeated at 5 Hz, and each tetanus including 3 different 10-burst trains separated by 15 s). Representative
traces of the fEPSPs before (trace 1) and after (trace 2) the induction of LTP in hippocampal slices from P7 saline- and 5-AzaC-treated adult mice. (C) A combined plot of the average of the
fEPSP slopes at several time points. Error bars, SEM (n= 5 mice/group; 10 slices/group). *p b 0.01 vs. saline.
25S. Subbanna et al. / Physiology & Behavior 167 (2016) 16–27into the CA1 region immediately after contextual fear conditioning
blocks memory formation [112]. DNMT inhibitors applied acutely to
adult brain slices in vitro or the adult hippocampus in vivo can inhibit
synaptic plasticity and learning andmemory [112–114]. In addition, im-
paired DNMT activity and the resulting reduction in DNA methylation
levels and DNA binding proteins were observed for in several genes as-
sociated with neurodegenerative disorders in adults (for references see
[115]). Recent studies suggest that DNA demethylation could be
achieved also through the teneleven translocation (Tet) family of
methylcytosine dioxygenases (Tet1, Tet2, and Tet3) [31]. Genetic dele-
tion of Tet1 impairs several synaptic plasticity-related genes, including
Arc, and induces abnormal hippocampal synaptic plasticity and im-
paired spatial [116] and contextual fear memory [117]. Although future
studies are required to understand the brain region specific epigenome
changes and their relationship to observed neurobehavioral deficits in
adult animals, our studies clearly suggest that the impairment of DNA
methylation during early brain development affects the expression of
survival factors [118] such as Arc [23] expression, inducing a delay in
neuronalmaturation [119]. Moreover, such impairmentmay be respon-
sible for the observed object, spatial and social recognitionmemory def-
icits and synaptic plasticity abnormalities in adult mice.
6. Conclusions
In summary, the experimental evidence from the current study re-
veals that 5-AzaC treatment at P7 inhibits DNA methylation, ERK1/2activation, and Arc expression, leading to neurodegeneration in neona-
tal mice and subsequently to impaired Arc expression and behavioral
abnormalities in adult mice. The current findings also suggest that the
mechanismbywhich 5-AzaC induces caspase-3 activation is significant-
ly independent of many upstream targets such as CB1R and G9a which
are known to be upregulated by alcohol in P7 mice [19,22–24,35,120,
121], though both produced a similar reduction in DNA methylation,
Arc expression along with long-lasting synaptic deficits. Understanding
the function of DNAmethylation during this distinct period of brain de-
velopment may shed light on the developmental origin of many adult
disabilities.Acknowledgments
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